Legal & General Group’s MaxCyte MXCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$19.5K Sell
8,963
-16,207
-64% -$35.3K ﹤0.01% 3010
2025
Q1
$68.2K Sell
25,170
-956
-4% -$2.59K ﹤0.01% 2696
2024
Q4
$107K Sell
26,126
-74,444
-74% -$305K ﹤0.01% 2719
2024
Q3
$392K Buy
100,570
+3,877
+4% +$15.1K ﹤0.01% 2541
2024
Q2
$380K Buy
96,693
+12,061
+14% +$47.4K ﹤0.01% 2511
2024
Q1
$355K Buy
84,632
+3,810
+5% +$16K ﹤0.01% 2559
2023
Q4
$380K Buy
80,822
+6,718
+9% +$31.6K ﹤0.01% 2557
2023
Q3
$231K Buy
74,104
+14,288
+24% +$44.6K ﹤0.01% 2692
2023
Q2
$275K Buy
59,816
+31,308
+110% +$144K ﹤0.01% 2664
2023
Q1
$141K Buy
28,508
+1,785
+7% +$8.84K ﹤0.01% 2702
2022
Q4
$146K Buy
26,723
+1,149
+4% +$6.27K ﹤0.01% 2713
2022
Q3
$166K Sell
25,574
-174,274
-87% -$1.13M ﹤0.01% 2685
2022
Q2
$942K Sell
199,848
-2,062
-1% -$9.72K ﹤0.01% 2185
2022
Q1
$1.43M Sell
201,910
-205,552
-50% -$1.46M ﹤0.01% 2111
2021
Q4
$4.16M Sell
407,462
-443,174
-52% -$4.53M ﹤0.01% 1673
2021
Q3
$10.4M Buy
+850,636
New +$10.4M ﹤0.01% 1159